Product
Self Vaginal FLOQSwabs®
Safe, comfortable, and easy to use, Self Vaginal FLOQSwabs® is the comfortable device supporting women taking part in HPV and STI screening campaigns.
Scientific study
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study
Marianna Martinelli et al.
Scientific study
Genotype heterogeneity of high-risk human papillomavirus infection in Ethiopia
Ayichew Seyoum et al.
Scientific study
Age-specific and genotype-specific carcinogenic human papilloma virus prevalence in a country with a high cervical cancer burden: results of across-sectional study in Estonia
Kersti Pärna et al.
Scientific study
Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer:implementation studies from five sub-Saharan African countries
Jessica Joseph et al.
Scientific study
Preliminary Results of Feasibility and Acceptability ofSelf-Collection for Cervical Screening in Italian Women
Illari Sechi et al.
Scientific study
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial
Rachel L. Winer et al.
Scientific study
Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples
Marianna Martinelli et al.
Scientific study
Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs
Michele Qi et al.
Scientific study
Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)
et al.
Scientific study
Addressing COVID-19 Screening Delays: The Impact of HPV Self-Sampling on Non-Attenders in a Cervical CancerScreening Program
A. Chiereghin et al.
Fair
EUROGIN 2022 – International multidisciplinary HPV congress
We urgently need to recover from the losses in cervical cancer screening and treatment and HPV vaccination rates that we witnessed during the COVID-19 pandemic; EUROGIN is the opportunity to meet in person to share ideas on the ambitious goal of eliminating cervical cancer. At the booth, you’ll have the chance to discover our solutions for HPV screening and our approach to self-collection as a method to increase testing rates in women.
Fair
GISCi – Convegno Gruppo Italiano Screening del Cervicocarcinoma
Il Gruppo Italiano Screening del Cervicocarcinoma è una associazione senza scopi di lucro che promuove la diffusione e miglioramento della qualità nell’attività di screening organizzato del carcinoma della cervice uterina. Il Convegno nazionale sarà un’occasione di confronto per quanti coinvolti nei programmi di screening organizzato nel verificare i risultati raggiunti, i programmi di recupero dopo il rallentamento dell’attività legato alla pandemia COVID, il grado di implementazione nell’attuazione del Programma Nazionale di Prevenzione per quanto attiene, nello specifico, l’attività dell’Associazione.
Fair
MyWoman International Congress 2023
MyWoman International Congress 2023 has a line-up of exciting topics and new developments in obstetrics, gynecology, menopause, and women’s health. This congress will be a platform for fostering new ideas, partnerships, and collaborations with many leading international experts to improve women’s health and well-being. We’ll be there with our products designed to empower women to self-collect their samples!
Fair
GISCi – Convegno Gruppo Italiano Screening del Cervicocarcinoma
Il Gruppo Italiano Screening del Cervicocarcinoma (GISCi ) è una associazione senza scopi di lucro che promuove la diffusione e miglioramento della qualità dell’ attività di screening organizzato del “carcinoma della cervice uterina”. Obiettivi principali del GISCi sono: promuovere i contatti tra i programmi di screening esistenti in Italia; favorire il confronto multidisciplinare tra i vari professionisti ed operatori coinvolti nel percorso di screening; promuovere la qualità dei programmi nonché sostenere e stimolare l’innovazione e la ricerca nel settore. Punto saliente per la valutazione del raggiungimento di tali obiettivi è il Convegno Nazionale annuale che quest’anno si terrà a Milano dal 26 al 27 Ottobre.
Sarà un’occasione di confronto per quanti coinvolti nei programmi di screening organizzato nel verificare i risultati raggiunti, i programmi di recupero dopo il rallentamento dell’attività legato alla pandemia COVID, il grado di implementazione nell’attuazione del Programma Nazionale di Prevenzione per quanto attiene, nello specifico l’attività della Associazione.
Fair
EUROGIN 2024
International Multidisciplinary HPV Congress of EUropean Research Organisation on Genital Infection and Neoplasia
Save the date and join us for another remarkable event as EUROGIN and its partners continue to advance the field of HPV research and cancer prevention. Started in 1993 as a conference where scientific progress and clinical practice converge, EUROGIN shares translational research with an international scientific community aiming at accelerating the reduction of the burden of HPV-related cancers and their mortality.
In cooperation with a highly recognized research groups, the EUROGIN 2024 conference draws up an inventory of recent scientific research to provide healthcare workers and decision-makers with a comprehensive strategy to fight diseases related to human papillomavirus.
The conference focuses on translating scientific and evidence-based research into clinical practice.
At the booth, you’ll have the chance to discover our solutions for HPV screening and our approach to self-collection as a method to increase testing rates in women.
Fair
2024 AOGIN – Asia-Oceania Research Organisation in Genital Infection and Neoplasia
This year’s topic is “Empowering Women, together against Cervical Cancer”, which is one of the biggest challenges of our time, combining women empowerment and genital infections. Copan has always been in the first line in fighting against STI diseases; therefore, we will attend the congress displaying our high-quality, STI-related products.
Fair
AOGIN India 2024
With the claim “Innovate, Empower, Educate,” AOGIN India collaborates closely with multidisciplinary healthcare groups, focuses on health promotion, training, community-based interventions, and cutting-edge research, and engages healthcare providers in women’s health for collaboration, scientific exchanges, education, and training, thus facilitating information dissemination.
Copan will be present at this important conference with our products related to women’s health.
Fair
36th International Papillomavirus Conference – IPVC
Join researchers, clinicians and other health professionals at the 36th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops. Conference topics include prevention of HPV infection and their associated diseases and cancers, especially cervical cancer; the molecular biology, immunology and epidemiology of PVs in understanding pathogenesis; expanding scientific knowledge to benefit the whole community, and so much more!
Copan is on the front line in fighting against cervical cancer and all HPV-associated disease, so you will find us at booth #18!
Fair
Asian Society Gynecologic Oncology Meeting 2024
Medical professionals who treat patients with gynecological cancer will come to Bali in order to discuss, exchange experiences, share research findings, and keep up to date on the latest developments in the field of gynecological cancer. A symposium and a pre-meeting course will be held to enhance knowledge and skills during the meeting.
We are proud to attend this significant meeting with our products for this specific application.
Fair
International Multidisciplinary HPV Congress of EUropean Research Organisation on Genital Infection and Neoplasia
EUROGIN is one of the world’s leading international congresses on HPV infections and associated cancers with a focus on prevention and diagnostics.
The event aims at translating scientific and evidence-based research into clinical practice through its high-quality and innovative program drawn up by outstanding international leaders. The conference offers a forum to exchange knowledge and experience with peers from all over the world.
Save the date and join us at booth A07, where you will ll have the chance to discover our solutions for HPV screening and our approach to self-collection as a method to increase testing rates in women.
Microbiology time
Microbiology Time – June 2022
June’s microbiology time is finally online! We selected three interesting studies for this month’s issue: a paper published on BMC evaluating HPV testing using self-collected samples and two studies on two very different outbreaks, the first of measles in Italian non-vaccinated individuals and the second investigating an outbreak of CPE in a COVID-19 intensive care unit.
Microbiology Time
Microbiology Time – February 2023
It’s the second month of 2023, and it’s the second microbiology time of the year! In this edition, we selected studies covering self-collected vaginal samples for molecular assays, SARS-Cov-2 detection from rectal and nasal swabs, and buccal swabbing for BRCA testing. Enjoy your reading!
Microbiology Time
Microbiology Time – March 2023
This month, we traveled From Ethiopia to Canada to collect three exciting studies to share on our Microbiology Time. From the analysis of the high-risk HPV infection prevalence in the African country to a veterinary case report on a lethal fungal infection in a captive bullfrog and a research paper amplifying human DNA from leeches to identify a victim or suspect of a crime. Enjoy!
Microbiology Time
Microbiology Time – September 2023
Here’s the ninth issue of 2023’s Microbiology Time. The three selected studies evaluate self- versus healthcare professional performed- collection, carcinogenic HPV prevalence in Estonia, and the implementation of molecular screening for HPV in five African countries.
Microbiology Time
Microbiology Time – October 2023
Let’s dig together into three thrilling papers on tongue swabs and tuberculosis, self-collection for cervical screening in Italian women, and a study on the correlation between Covid-related olfactory deficit and zinc homeostasis.
Microbiology Time
Microbiology Time – February 2024
In the second Microbiology Time of 2024, we selected a paper proposing salivary micro-RNA as a liquid biopsy marker in oral cancer, a clinical trial evaluating different methods of offering HPV self-sampling kits, and a study investigating the benefits of probiotics in improving microbiota composition in post-menopausal women.
Microbiology Time
Microbiology Time – July 2024
We welcome the long-awaited summer with three great papers: the first analyzes surface characteristics’ effect on human DNA’s recovery for forensic purposes, while the second and third evaluate the impact of different variables on the accuracy and usability of self-collected samples for HPV detection.
Microbiology Time
Microbiology Time – August 2024
To select this month’s studies, we’ve traveled to three continents with an epidemiology study on pneumococcus in Botswana, an update on the British HPV screening program YouScreen, and an E. coli sequencing project in Pakistan.
Microbiology Time
Microbiology Time – January 2025
The effects of COVID-19 on HPV screening, athlete-derived probiotics to enhance health and wellness, and subsampling in forensic science—this is all featured in the first edition of this year’s Microbiology Time!
